FindTrial
Sign In

The efficacy and safety of framework-fill embolization using coils combined with cyanoacrylate for large spontaneous shunts (L-SPSS) during transjugular intrahepatic portosystemic shunt (TIPS)

The efficacy and safety of framework-fill embolization using coils combined with cyanoacrylate for large spontaneous shunts (L-SPSS) during transjugular intrahepatic portosystemic shunt (TIPS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109655
Enrollment
Unknown
Registered
2025-09-23
Start date
2025-09-30
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal hypertension

Interventions

Frame-and-fill Embolization group:Anterograde Frame-and-fill Embolization with Coil and Cyanoacrylate for Large Spontaneous Portosystemic Shunt during Transjugular Intrahepatic Portosystemic Shunt.

Sponsors

Sun Yat-sen University Cancer
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Enhanced CT/MRI or DSA angiography confirms L-SPSS secondary to portal hypertension with a diameter of = 8mm; (2) Acute or recurrent esophageal and gastric fundus variceal rupture bleeding, and/or refractory ascites, and/or recurrent hepatic encephalopathy; (3) Complete and reliable clinical data are required; (4) The follow-up period should be at least 6 weeks or death is confirmed.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Technical success rate;—

Secondary

MeasureTime frame
6-week mortality;The incidence of postoperative adverse events;—

Countries

China

Contacts

Public ContactGao Fei

Sun Yat-sen University Cancer Center

gaof@sysucc.org.cn+86 137 6086 9828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026